Indwelling Pleural Catheter for Trapped Lung

Pleura; Effusion Clinical Trial

Official title: Indwelling Pleural Catheter for Trapped Lung: a Pilot Study for Power Calculation of a Randomized Controlled Trial Comparing Pleurocath® Versus PleurX®)

Status Completed

Clinical Trial Summary

Malignant pleural effusion (MPE) is a complication of almost any site of primary cancer as well as primary tumors of the pleura. Half of MPE patients have non-expendable trapped lungs not suitable for talc pleurodesis. Indwelling pleural catheters (IPCs), however, can be used in this cohort of patients, bringing about an improvement in dyspnea and quality of life (QOL).

The aim of this study is to obtain pilot data - comparing patients receiving two different types of indwelling pleural catethers normally used in clinical practice (10 patients receiving Pleurocath® and 10 patients receiving PleurX®) - for power calculation of a Randomized Controlled Trial comparing two different drainages for MPE trapped lung.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Pleura; Effusion
• Pleural Effusion

• NCT number: NCT03550027
• Study type: Interventional
• Source: European Institute of Oncology
• Status: Completed
• Phase: Phase 3
• Start date: April 21, 2017
• Completion date: February 15, 2018